The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.

about

Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.

P2860

Q52617485-718D3BE9-600C-4E74-B7CC-9ED81D9974B1

P2860

The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.

Item

http://www.wikidata.org/entity/Q47103766

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The role of anti-EGFR agents i ...... analysis of randomized trials.

@en

The role of anti-EGFR agents i ...... analysis of randomized trials.

@nl

type

Item

label

The role of anti-EGFR agents i ...... analysis of randomized trials.

@en

The role of anti-EGFR agents i ...... analysis of randomized trials.

@nl

prefLabel

The role of anti-EGFR agents i ...... analysis of randomized trials.

@en

The role of anti-EGFR agents i ...... analysis of randomized trials.

@nl

P1476

The role of anti-EGFR agents i ...... analysis of randomized trials.

@en

P2093

Bum Jun Kim

http://www.w3.org/2001/XMLSchema#string

Hyeong Su Kim

http://www.w3.org/2001/XMLSchema#string

Jae Ho Jeong

http://www.w3.org/2001/XMLSchema#string

Jung Han Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Practical methods for incorporating summary time-to-event data into meta-analysis

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014

P304

102371-102380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21987

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29254252

http://www.w3.org/2001/XMLSchema#string

P932

5731962

http://www.w3.org/2001/XMLSchema#string

The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.

about

P2860

P2860

The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932